Marketview360 Logo
ScreensWatchlistMarketsNewsAI AssistantPricing
⌘K
Marketview360 Logo

The fastest way to screen, analyze, and track US equities. Real-time data, powerful ratios, and clean design for the modern investor.

Product

  • Stock Screener
  • Market Overview
  • Market News
  • AI Assistance

Support

  • Help Center
  • Feedback
  • About
  • Blog
  • System Status

© 2026 Marketview360 Inc. All rights reserved.

PrivacyTermsCookiesDisclaimer
Home/
Screener/
GILD.US
Gilead Sciences Inc logo

Gilead Sciences Inc

GILD.US
NASDAQ•Healthcare
Low: $91.47High: $157.29
$134.25
52 Week Range
-1.92%
Market Close
Key Metrics
Peer Comparison
TickerNamePriceMkt CapP/E1D %
ABBV.USAbbVie Inc$410.36B97.92-0.81%
BSX.USBoston Scientific Corp$114.04B39.61-1.43%
EXAS.USEXACT Sciences Corporation$19.73B0.00-0.68%
WST.USWest Pharmaceutical Services Inc$18.32B37.46-1.92%
BPMC.USBlueprint Medicines Corp$8.37B0.000.14%
MOH.USMolina Healthcare Inc$7.93B17.273.24%
MMED.USMiniMed Group, Inc. Common Stock$4.48B0.00-5.24%
AMRX.USAmneal Pharmaceuticals, Inc. Class A Common Stock$4.34B1381.00-1.74%
BCRX.USBioCryst Pharmaceuticals Inc$1.87B0.00-2.41%
NBTX.USNanobiotix$1.50B0.00-4.37%
Latest News

No recent news available for GILD.US

See news for other symbols →
Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Ode…

Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
17,000
Founded
1992
Country
Not available
Website
https://www.gilead.com
Analyst Ratings
Buy
Target: $156.59(+16.6%)
Based on 30 analysts
0
Strong Sell
0
Sell
11
Hold
4
Buy
15
Strong Buy